Immuron Limited Total Liabilities 2011-2026 | IMRN

Annual Total Liabilities Immuron Limited

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.68 M	1.16 M	558 K	-	-	-	-	-	-	-	-	-

All numbers in AUD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.68 M	558 K	1.13 M

Quarterly Total Liabilities Immuron Limited

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	1.68 M	-	-	-	1.16 M	-	-	-	558 K	-	-	-	1.21 M	-	-	-	803 K	-	-	-	1.71 M	-	-	-	3.89 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in AUD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.89 M	558 K	1.57 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	390 M	$ 3.44	-4.32 %	$ 1.03 B	Canada
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
ADMA Biologics ADMA	147 M	$ 15.36	-2.17 %	$ 3.66 B	USA
Cellectis S.A. CLLS	253 M	$ 3.53	-3.54 %	$ 116 M	France
AgeX Therapeutics AGE	6.61 M	-	-10.17 %	$ 12.2 K	USA
Apellis Pharmaceuticals APLS	705 M	$ 20.28	0.65 %	$ 2.56 B	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
Nymox Pharmaceutical Corporation NYMX	7.43 M	-	-19.68 %	$ 18.4 M	Canada
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
Aptorum Group Limited APM	4.35 M	$ 0.79	-1.15 %	$ 4.31 M	China
Autolus Therapeutics plc AUTL	355 M	$ 1.51	1.35 %	$ 385 M	Britain
China SXT Pharmaceuticals SXTC	6.22 M	$ 2.01	-1.36 %	$ 2.86 M	China
Galmed Pharmaceuticals Ltd. GLMD	8.23 M	$ 0.67	7.08 %	$ 624 K	Israel
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Anika Therapeutics ANIK	42.3 M	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	855 M	$ 74.36	-1.64 %	$ 1.44 B	USA
Applied Therapeutics APLT	72 M	-	-	$ 8.42 M	USA
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
Athersys ATHX	28.4 M	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	59.5 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	602 M	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	966 M	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	3.01 B	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
Brainstorm Cell Therapeutics BCLI	9.6 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	137 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	3.83 B	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
Bellicum Pharmaceuticals BLCM	3.77 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	84 M	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
BioLineRx Ltd. BLRX	25.4 M	$ 2.69	-0.74 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	1.51 B	$ 61.3	1.21 %	$ 11.8 B	USA
Burford Capital Limited BUR	1.45 B	$ 7.79	-5.75 %	$ 1.28 B	Britain
CymaBay Therapeutics CBAY	142 M	-	-	$ 3.45 B	USA